Carissa Chu retweeted
Congrats to all authors that contributed chapters to our book on the major complication of pelvic surgery in female pts. Doody's Review provided it with a rare 5 Star review. Useful to all pelvic surgeons.
@UrologyMSK @UroOnc @AmerUrological @SGO_org
link.springer.com/book/10.1007/9…
@UrologyMSK @UroOnc @AmerUrological @SGO_org
link.springer.com/book/10.1007/9…
4
5
30
1,801
Carissa Chu retweeted
Lymphocele cited as major reason in guidelines to avoid LND in prostate cancer. Here we show most almost all lymphoceles (42/43) come from Cloquet's node, which should not be removed during LND. auajournals.org/doi/10.1097/JU…
3
14
60
7,504
Carissa Chu retweeted
Congratulations to @WesleyYipMD who received this year's Barry Hoeven Memorial Kidney Cancer Research Project Award! #ForaKure #KureIt #CancerResearch
1
4
15
2,031
Carissa Chu retweeted
Congratulations to Mary-Ellen Taplin, MD, recipient of the 2026 PCF Women in Science Lifetime Achievement Award.
She asked in 1995 why prostate cancer stops responding to hormone therapy, then spent decades turning that answer into standard care.
#PCFRetreat26
She asked in 1995 why prostate cancer stops responding to hormone therapy, then spent decades turning that answer into standard care.
#PCFRetreat26
0
10
35
1,142
Carissa Chu retweeted
At the Dr. Felix Feng Legacy Lecture at #PCFRetreat26, Joshua Lang, MD, shares “50 Lessons in Life, Leadership, and Science that Matters,” honoring Dr. Feng’s legacy while inspiring the next generation of physician-scientists.
#ScientificRetreat
#ScientificRetreat
0
7
32
1,683
Carissa Chu retweeted
Applications open for 2026 PCF Leadership Academy (Dec 3–5, Santa Monica). For U.S. trainees and early- to mid-career physicians focused on community prostate cancer care. Build skills, connect with expert mentors. We cover travel and hotel. Apply here: pcf.org/our-impact/med…
0
3
5
775
Thank you to @BladderCancerUS for this support!
The UCSF K12 from the NCI went unfunded in 2025 with several junior faculty already in the program. Foundations like BCAN make all the difference in steadying the waters in an uncertain federal funding landscape.
The UCSF K12 from the NCI went unfunded in 2025 with several junior faculty already in the program. Foundations like BCAN make all the difference in steadying the waters in an uncertain federal funding landscape.
“This support will allow me to sustain the momentum of my laboratory, continue pursuing promising new discoveries, and bridge a critical funding gap.”
Congratulations to 2026 BCAN Continuity Grant recipient @CChuMD!
0
5
35
2,233
Carissa Chu retweeted
🚨 Retroperitoneal fibrosis 🚨
@TheLancet, worth a read by urologist
📌 Ureteral encasement w/ obstructive uropathy in 60-70% of cases.
📌Many pts present w/ hydronephrosis
📌 Serum IgG4 is normal in 60 to 70% of idiopathic cases
📌 Occupational asbestos + smoking = risk nts:
✅ Stent or nephrostomy for moderate to severe obstruction, then immunosuppression.
✅ Ureterolysis is rescue therapy for intractable obstruction, not first line
✅ Pull urologic hardware once the fibrosis shrinks
⚠️~42% relapse, median 14 months. 20 to 50% develop CKD
⚠️ Atypical location, bulky mass, or lateral ureteral displacement should trigger biopsy
🎯 RPF is a systemic fibro-inflammatory disease
-Urology job is drainage & getting pts to medical therapy
🔗 doi.org/10.1016/S0140-…
@AmerUrological @urotoday @UrologyTimes
@TheLancet, worth a read by urologist
📌 Ureteral encasement w/ obstructive uropathy in 60-70% of cases.
📌Many pts present w/ hydronephrosis
📌 Serum IgG4 is normal in 60 to 70% of idiopathic cases
📌 Occupational asbestos + smoking = risk nts:
✅ Stent or nephrostomy for moderate to severe obstruction, then immunosuppression.
✅ Ureterolysis is rescue therapy for intractable obstruction, not first line
✅ Pull urologic hardware once the fibrosis shrinks
⚠️~42% relapse, median 14 months. 20 to 50% develop CKD
⚠️ Atypical location, bulky mass, or lateral ureteral displacement should trigger biopsy
🎯 RPF is a systemic fibro-inflammatory disease
-Urology job is drainage & getting pts to medical therapy
🔗 doi.org/10.1016/S0140-…
@AmerUrological @urotoday @UrologyTimes
1
32
109
7,314
Carissa Chu retweeted
Just released in @NatRevUrol : Integrating clinically actionable biomarkers into bladder cancer care : recommendations from the International Bladder Cancer Group @IBCG_BladderCA
During our deliberations, one theme was clear: biomarkers don't improve care simply because they're rove care when they're validated, reproducible, and actually change clinical decisions 🧵
@pjhensley11 @jteoh_hk @UrogerliMD @shilpaonc @LauraBukavinaMD @mouwlab @AndreaNecchi @niyatilobo @Agarwal_CaB @LiangChengMD @karima_oualla @drtanws @MaxKates @BrigidaMaiorano @h_alahmadie @TomFlaigMD @AmirHorowitz @WesKassouf @djmcconkey @JanetKukreja @LAUrology_NL @carme_mir1 @UroMoschini @BogdanaSchmidt @VigneshPackiam
During our deliberations, one theme was clear: biomarkers don't improve care simply because they're rove care when they're validated, reproducible, and actually change clinical decisions 🧵
@pjhensley11 @jteoh_hk @UrogerliMD @shilpaonc @LauraBukavinaMD @mouwlab @AndreaNecchi @niyatilobo @Agarwal_CaB @LiangChengMD @karima_oualla @drtanws @MaxKates @BrigidaMaiorano @h_alahmadie @TomFlaigMD @AmirHorowitz @WesKassouf @djmcconkey @JanetKukreja @LAUrology_NL @carme_mir1 @UroMoschini @BogdanaSchmidt @VigneshPackiam
5
38
78
14,849
Carissa Chu retweeted
Excited 4 the inaugural #FUO26 with SUO Leadership supporting a 3 day symposium to share what a career w/in the @UroOnc provides
Interactive discussions, dz focused sessions, career develop. opportunities + an intro to a community focused on Ca biology and multi-D treatment
Interactive discussions, dz focused sessions, career develop. opportunities + an intro to a community focused on Ca biology and multi-D treatment
3
10
36
2,711
Carissa Chu retweeted
9/ This is true across fields.
In oncology, fellowship cannot only mean doing the index operation. It has to mean multidisciplinary cancer management, salvage surgery, collaboration with other specialites, and trials.
In recon, it is redo surgery, radiated fields, and anatomy that isn't in the textbook.
In oncology, fellowship cannot only mean doing the index operation. It has to mean multidisciplinary cancer management, salvage surgery, collaboration with other specialites, and trials.
In recon, it is redo surgery, radiated fields, and anatomy that isn't in the textbook.
1
3
27
3,858
Carissa Chu retweeted
13/ So yes, fellowship interest is changing. Good.
The old question was: “Should I do a fellowship or join a subspecialty?”
The better question is: “What will this fellowship make me?”
A better surgeon.
A better thinker.
A better collaborator.
A better job candidate.
A urologist with a name attached to a problem others know to send.
The old question was: “Should I do a fellowship or join a subspecialty?”
The better question is: “What will this fellowship make me?”
A better surgeon.
A better thinker.
A better collaborator.
A better job candidate.
A urologist with a name attached to a problem others know to send.
2
6
52
7,059
RT @UCSFUrology: We are thrilled to announce our 2027AY Onc fellow - Wes Chou from OHSU - Welcome to the UCSF Urology family! t.co…
0
5
0
Carissa Chu retweeted
Congrats to our stellar class of graduates! Looking forward to celebrating tonight!
1
11
45
7,090
Carissa Chu retweeted
Congratulations to Dr. Daniela Orozco Rendon, recipient of the 2025–26 Krevans Award!! This award honors outstanding PGY-1 residents for their clinical excellence, compassion, professionalism, and teamwork! 💫
urology.ucsf.edu/news/all/20260…
urology.ucsf.edu/news/all/20260…
1
1
14
837
Carissa Chu retweeted
Please join us for our upcoming Grand Rounds with a presentation by our Emil A. Tanagho Visiting Professor, Dr. Daniel Lin!
🗓️ Friday, June 5, 2026
⏰ 8:00 am-9:00 am PDT
💻 Register for Zoom webinar: ucsf.zoom.us/webinar/regist…
🗓️ Friday, June 5, 2026
⏰ 8:00 am-9:00 am PDT
💻 Register for Zoom webinar: ucsf.zoom.us/webinar/regist…
0
2
12
1,388